Zyden Gentec has informed that a meeting of the board of directors of the company will be held on February 11, 2013, to consider and take on record unaudited financial results of the company for the third quarter/ nine months ended as on December 31, 2012.
To consider and adopt limited review report for the third quarter as on December 31, 2012 obtained from auditor of the company, to take on record the incorporation of 100% wholly owned subsidiary in Hong Kong in the name of Zyden Gentec Hong Kong and to consider and take on record the resolution passed by circulation regarding registration under DIC Scheme for benefit of employees.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1875.00 |
| Dr. Reddys Lab | 1283.90 |
| Cipla | 1336.45 |
| Zydus Lifesciences | 939.65 |
| Lupin | 2250.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: